Search

everythinglearnresearchcommunity

for

Search:↓

El plasma rico en plaquetas puede ayudar en la regeneración celular y podría ser útil en tratamientos complementarios para enfermedades sin cura específica.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

People with alopecia areata often have lower vitamin D levels than healthy people.

Many research paper titles in dermatology journals lack scientific precision.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

Non-infectious skin issues like eczema are common in rural areas, especially in men aged 40-60.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

New cytokine-targeted therapies show promise for treating alopecia areata.

New treatments for severe alopecia areata show promise but lack standard approval.

Medical students lack awareness of plastic surgery's full scope, and more education is needed.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

The document concludes that transplantology has evolved with improved techniques and materials, making transplants more successful and expanding the types of transplants possible.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

The document explains the causes, types, diagnosis, and treatments of hair loss, and its psychological impact, especially on women.

Some natural remedies may help with hair regrowth, but more research is needed to confirm their effectiveness and safety.

The document concludes that a complete skin restoration biomaterial does not yet exist, and more clinical trials are needed to ensure these therapies are safe and effective.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

The document concludes that dermatology training and grading scales need to better represent dark-skinned individuals to improve diagnosis and assessment of skin conditions.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Low vitamin D levels may worsen or cause alopecia areata.

Cancer survivors need better skin care to improve their quality of life.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Moderate facial angiofibroma significantly reduces quality of life compared to almost-clear cases, highlighting the benefits of treatment.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Poor sleep may lead to hair loss, and hair loss may affect sleep.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Facial trichostasis spinulosa is a chronic condition with significant cosmetic impact, especially in young women.